Clarithromycin

Clarithromycin

SCHEMBL28595772

CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O.O=S(=O)(O)O

nearest known ligand 0.95

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Clarithromycin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 10/20 0.95
KCNH2 Q12809 5/20 0.95
SLCO1B3 Q9NPD5 3/20 0.95
SLCO1B1 Q9Y6L6 3/20 0.95
ABCB1 P08183 2/20 0.95
MAPK1 P28482 2/20 0.95
AR P10275 1/20 0.95
MLNR O43193 2/20 0.88
TSHR P16473 2/20 0.88
LMNA P02545 2/20 0.88
TDP1 Q9NUW8 1/20 0.88
ALB P02768 1/20 0.88
CNR1 P21554 1/20 0.88
HTR2A P28223 1/20 0.88
AOX1 Q06278 1/20 0.88
CYP1B1 Q16678 1/20 0.88
ABCB11 O95342 2/20 0.80
ABCC4 O15439 1/20 0.80
PGR P06401 1/20 0.74
HTR1A P08908 1/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Clarithromycin SCHEMBL7870339 0.98 CYP3A4 (0.94) CYP3A4KCNH2SLCO1B3SLCO1B1ABCB1
Clarithromycin SCHEMBL7870336 0.98 CYP3A4 (0.94) CYP3A4KCNH2SLCO1B3SLCO1B1ABCB1
Clarithromycin SCHEMBL5971354 0.97 CYP3A4 (0.92) CYP3A4KCNH2SLCO1B3SLCO1B1ABCB1
Clarithromycin SCHEMBL5971358 0.97 CYP3A4 (0.92) CYP3A4KCNH2SLCO1B3SLCO1B1ABCB1
Clarithromycin SCHEMBL23309064 0.97 CYP3A4 (1.00) CYP3A4KCNH2SLCO1B3SLCO1B1ABCB1
Clarithromycin SCHEMBL38125 0.97 CYP3A4 (1.00) CYP3A4KCNH2SLCO1B3SLCO1B1ABCB1
Clarithromycin SCHEMBL17616076 0.97 CYP3A4 (1.00) CYP3A4KCNH2SLCO1B3SLCO1B1ABCB1
Clarithromycin SCHEMBL23854898 0.97 CYP3A4 (1.00) CYP3A4KCNH2SLCO1B3SLCO1B1ABCB1
Clarithromycin SCHEMBL12296733 0.97 CYP3A4 (1.00) CYP3A4KCNH2SLCO1B3SLCO1B1ABCB1
Clarithromycin SCHEMBL17705916 0.97 CYP3A4 (1.00) CYP3A4KCNH2SLCO1B3SLCO1B1ABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113913450-A Method for expressing chitosanase by using rhodopseudomonas palustris, chitosanase, recombinant plasmid, recombinant bacterium, fermentation inoculant and application 湖南省植物保护研究所 2022-01-11 CN claimed
CN-114832783-B Adsorption material, preparation method and cleaning method 成都思文凌云科技有限公司 2024-03-12 CN disclosed
CN-114832783-A Adsorbing material, preparation method and cleaning method 成都思文凌云科技有限公司 2022-08-02 CN disclosed
CN-113186208-B Eukaryotic recombinant plasmid and application thereof in improving tomato fruit pigment accumulation 合肥工业大学 2022-07-15 CN disclosed
CN-114527054-A Method for researching stability and intracellular localization of phosphorylated p53 based on phase separation 华南理工大学 2022-05-24 CN disclosed
CN-113913450-A Method for expressing chitosanase by using rhodopseudomonas palustris, chitosanase, recombinant plasmid, recombinant bacterium, fermentation inoculant and application 湖南省植物保护研究所 2022-01-11 CN disclosed
CN-113186208-A Eukaryotic recombinant plasmid and application thereof in improving tomato fruit pigment accumulation 合肥工业大学 2021-07-30 CN disclosed